False World Vs. Real World: A Strong Argument for RWD

Lucy Brake speaks to Mike Rea, CEO of IDEA Pharma, about how he believes real world evidence impacts current development and trials processes, and the ways in which pharma can take best take advantage of all this offers. Read entire article here. (Source: eyeforpharma, May 16, 2013)

You might also be interested in:

Real World Data Capabilities: Benchmarking Pharma Companies October 30, 2018
eDossier System to Offer hēRo3 Model Integration November 8, 2018
FirstWord Report Looks at Pharma Perspective on RWD October 30, 2018
RWE: Opportunity, Challenges and Sourcing Simplified November 30, 2018
Eyeforpharma Webinar to Spotlight Blockchain June 25, 2018
Article: Rise of Digital Health Data Bolsters Interest in RWD August 18, 2018
ICER Publishes Guidance on Improving Development, Use of RWE… April 11, 2018